Labshake search
Citations for Invivogen :
1 - 50 of 482 citations for 8 8 dimethylpyrano 2 3 h chromen 2 one since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2020Quote: ... plus the TLR-7 and TLR-8 agonist Resiquimod (R848, 2 µM, InvivoGen), for 24 h ...
-
bioRxiv - Microbiology 2023Quote: ... TLR7/8 agonist (R848, 8 μg/mL, InvivoGen) or exposed to vRNPs in virus-cleared SN from infected (24 hpi ...
-
bioRxiv - Neuroscience 2021Quote: ... one from Invivogen of high molecular weight (HMW) (1.5 kb – 8 kb) and one from Invivogen of low molecular weight (LMW ...
-
bioRxiv - Cell Biology 2019Quote: ... 2’,3’-cGAMP (Invivogen) at 10 μg/mL ...
-
bioRxiv - Immunology 2022Quote: ... 2′3′- cyclic-di-GMP-AMP (2′3′-cGAMP) (Invivogen cat. no. tlrl-nacga23), and human IFN-β (PeproTech ...
-
bioRxiv - Immunology 2022Quote: ... 2′3′-RR c-di-AMP (2′3′-RR-S2 CDA) (Invivogen cat. no. tlrl-nacda2r), 2′3′- cyclic-di-GMP-AMP (2′3′-cGAMP ...
-
bioRxiv - Immunology 2023Quote: ... 2′-3′cGAMP was from InvivoGen, human recombinant sTREM2 was from Sino Biological ...
-
bioRxiv - Bioengineering 2023Quote: ... or ss-ppp-miRNA-21 (2, 4 or 8 µg/ml) were transfected into the cells using LyoVec™ (Catalog Code, lyec-12, InvivoGen), following the manufacturer’ ss instructions ...
-
bioRxiv - Bioengineering 2023Quote: ... or ss-miRNA-21 (2, 4 or 8 µg/ml) were transfected into the cells using LyoVec™ (InvivoGen, Catalog Code. lyec-12, InvivoGen) following the manufacturer’ ss instructions ...
-
bioRxiv - Immunology 2021Quote: ... or 2’-3’cGAMP (4µg/ml, Invivogen) for the specified times ...
-
bioRxiv - Immunology 2024Quote: ... or 2µg/mL 2’,3’-cGAMP (InvivoGen), or 2µg/mL poly(I:C ...
-
bioRxiv - Microbiology 2021Quote: ... and 8 μg/ml blasticidin (InvivoGen) for 3-5 d at 37°C ...
-
bioRxiv - Microbiology 2021Quote: ... and 8 μg/ml blasticidin (InvivoGen) in growth medium for 5 days at 37°C ...
-
bioRxiv - Microbiology 2021Quote: ... and 8 μg/ml blasticidin (InvivoGen) for 3-5 d at 37°C ...
-
bioRxiv - Immunology 2023Quote: ... the cells were pre-incubated with the respective antagonist as suggested by the manufacturer’s protocol (STING: H-151 for 1-2 hours and cGAS: RU.521 for 3 hours, both InvivoGen, USA) in cell growth medium ...
-
bioRxiv - Immunology 2023Quote: ... HEK-293T cells overexpressing hTLR7/8 (HEK-Blue-TLR7/8) were purchased from InvivoGen (San Diego, California, USA) and cultured in DMEM supplemented with 10% (vol/vol ...
-
bioRxiv - Immunology 2021Quote: ... a specific TLR7/8 agonist (5μM, Invivogen) as positive control ...
-
bioRxiv - Immunology 2023Quote: ... diABZI (Invivogen, cat no. 2138299-34-8), 2’3’-cGAMP (Invivogen ...
-
bioRxiv - Immunology 2024Quote: ... TLR7/8 agonist (R848 ; Invivogen, cat #tlrl-r848) at 0,5 μg/mL each ...
-
bioRxiv - Bioengineering 2023Quote: ... 4 or 8 µg/ml) or ss-miRNA-21 (2, 4 or 8 µg/ml) were transfected into the cells using LyoVec™ (InvivoGen, Catalog Code. lyec-12, InvivoGen) following the manufacturer’ ss instructions ...
-
bioRxiv - Systems Biology 2021Quote: ... 2’,3’-cyclic GMP-AMP (cGAMP) (Invivogen #tlrl-nacga23-5) at a concentration of 1 mg/mL (final concentration in the well 100 ug/mL ...
-
bioRxiv - Immunology 2024Quote: ... BMDMs were further incubated with Nigericin (8 μM, Invivogen) for an additional 90 minutes.
-
bioRxiv - Neuroscience 2024Quote: ... for 8 hours and ATP (10nM)(InvivoGen, tlrl-atpl) for 30 minutes ...
-
bioRxiv - Immunology 2021Quote: ... 2’-3’-cGAMP and c-di-UMP were purchased from Invivogen. EFV was purchased from Bristol-Myers Squibb.
-
Nucleic acid sensing by STING induces an interferon-like antiviral response in a marine invertebratebioRxiv - Immunology 2022Quote: ... Elution was performed with free 2′3′-cGAMP (100 μM; InvivoGen), 3′3′-cGAMP (100 μM ...
-
bioRxiv - Cancer Biology 2023Quote: ... In some cases, cells were first pre-treated for 1 h with following inhibitors (2 µM H-151, 10 µM MCC950 (InvivoGen)) before addition of the treatments ...
-
bioRxiv - Immunology 2021Quote: ... and 8 μg of CpG (Cat: TLRL-1826-1, Invivogen) were administered to mice on days 0 and 14 ...
-
bioRxiv - Immunology 2020Quote: ... and R848 (TLR7/8; tlrl-r848; Invivogen, 100 ng/ml) for 4 hours ...
-
bioRxiv - Immunology 2022Quote: ... the medium was supplemented with 8 μg/ml blasticidin (Invivogen). 4T1 and 4T1-Luc2 cells were transfected with a plasmid DNA encoding a fusion protein of the nucleoproteins of SARS-CoV-2 and MERS-CoV (non-secreted form ...
-
bioRxiv - Neuroscience 2023Quote: ... Puromycin (Puro, 0.5 - 8 µg/mL Invivogen, ant-pr-1), Doxycycline hyclate (Dox ...
-
bioRxiv - Immunology 2023Quote: ... or 10 µM of TLR 8 inhibitor (Cu-CPT9a, Invivogen) were incubated with MDMs 3h prior to infection ...
-
bioRxiv - Cell Biology 2023Quote: ... 4 µM digitonin) with or without 7 µM 2’,3’-cGAMP (Invivogen). Cells were further washed in PBS and incubated in culture medium until collection ...
-
bioRxiv - Pharmacology and Toxicology 2020Quote: ... 8 and 9 cell lines were purchased from InvivoGen (Hong Kong). The cells express the human TLR gene and NF-κB/AP-1-inducible SEAP (secreted embryonic alkaline phosphatase ...
-
bioRxiv - Genetics 2019Quote: ... For stable sgRNA and shRNA expression 3 days puromycin (2 μg/ml, Invivogen) selection was applied.
-
Increased dosage of wild-type KRAS protein drives KRAS-mutant lung tumorigenesis and drug resistancebioRxiv - Cancer Biology 2024Quote: ... Infected cells were selected using puromycin for 3 days (2 µg/ml, InvivoGen) or hygromycin B for 7 days (500 µg/ml ...
-
bioRxiv - Pathology 2020Quote: ... followed by antibiotic-mediated selection (8 μg/mL puromycin, Invivogen, #ant-pr).
-
bioRxiv - Immunology 2022Quote: ... 2 ug/mL Pam3CSK4 (TLR1/2 agonist, Invivogen), and 1 ug/mL FSL-1 (TLR2/6 agonist ...
-
bioRxiv - Bioengineering 2023Quote: ... and absorbance levels were detected at 655 nm after 2 h incubation with QUANTI-Blue Solution (Invivogen). Nonlinear regression fits were estimated using the “Log(agonist ...
-
bioRxiv - Bioengineering 2021Quote: ... and 2 µl/ml primicin (Ant-pm-2, InvivoGen) at 37°C for 19 hours.
-
bioRxiv - Bioengineering 2022Quote: ... and 2 μl/ml primocin (Ant-pm-2, InvivoGen) at 37°C for 19 hours ...
-
bioRxiv - Immunology 2020Quote: ... Cells were treated with 12.5 or 25 μg/mL 2’-3’cGAMP (Invivogen tlrl-nacga23) for 2 hr as indicated ...
-
bioRxiv - Immunology 2021Quote: ... Cells were then stimulated with the TLR-7/8 agonist Resiquimod – R848 (Invivogen) at 5 μg/mL ...
-
bioRxiv - Immunology 2021Quote: ... 1×106 PBMC were stimulated with 1ug/ml R848 (TLR7/8 agonist; Resiquimod (Invivogen)) diluted in complete RPMI (cRPMI ...
-
bioRxiv - Immunology 2021Quote: ... Labeled cells (0.5x106 cells/mL) were cultured for 2-3 days with 5 μg/mL R848 (InvivoGen), 50 U/mL IL-2 (Peprotech) ...
-
bioRxiv - Microbiology 2024Quote: ... providing an additional metric for assessing cell health post-drug treatment for both 2’-3’cGAMP (Invivogen) and Sulfasalazine (Cayman Chemical).
-
bioRxiv - Bioengineering 2022Quote: ... and stimulated with 1 μg/mL R848 (TLR7/8 agonist; InvivoGen, Inc.; San Diego, CA) and 5 μg/mL of CD40 antibody ligand (clone ...
-
bioRxiv - Immunology 2020Quote: ... The supernatants were discarded before staining with 50 μL of 2 μg/mL secondary AF488 goat anti rabbit (goat IgG H+L, Invivogen) in cytometry buffer for 30 min on ice ...
-
bioRxiv - Immunology 2023Quote: ... for 2 h and then stimulated with 20 ng/mL of recombinant human mIL-1β (R&D) complexed with Lyovec (Invivogen). Activation was carried out for 18 h unless stated differently ...
-
bioRxiv - Immunology 2023Quote: ... followed by the medium being replaced with fresh IFNγ (5 ng/ml) containing media for 2 h before treatment with indicated stimulations: MDP (100 μM, Invivogen), iE-DAP (100 μM ...
-
bioRxiv - Molecular Biology 2021Quote: ... or on solid YPD-agar (1% yeast extract, 2% peptone, 2% D-glucose, 2% agar) and selected with 100 µg/ml Zeocin® (InvivoGen). For small scale expression screening ...